(Q54281667)

27 May 2018

title

Effects of angiotensin converting enzyme inhibition in adult polycystic kidney disease (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1317477

12 September 2022

1 reference

5 December 2023

author name string

M. L. Watson

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1317477

12 September 2022

A. M. Macnicol

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1317477

12 September 2022

P. L. Allan

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1317477

12 September 2022

A. F. Wright

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1317477

12 September 2022

language of work or name

English

0 references

publication date

1 January 1992

1 reference

27 May 2018

full work available at URL

https://doi.org/10.1038/ki.1992.28

online access status

open access

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1317477

https://api.elsevier.com/content/article/PII:S0085253815574498?httpAccept=text/xml

5 December 2023

1 reference

https://api.elsevier.com/content/article/PII:S0085253815574498?httpAccept=text/plain

5 December 2023

1 reference

5 December 2023

1 reference

27 May 2018

volume

41

1 reference

27 May 2018

page(s)

206-210

1 reference

27 May 2018

issue

1

1 reference

27 May 2018

https://scigraph.springernature.com/pub.10.1038/ki.1992.28

exact match

0 references

cites work

Hypertension in polycystic kidney disease

1 reference

https://api.crossref.org/works/10.1038%2FKI.1992.28

7 January 2021

Hypertension in polycystic kidney disease without renal failure

1 reference

https://api.crossref.org/works/10.1038%2FKI.1992.28

7 January 2021

Hypertension of polycystic kidney disease: mechanisms and hemodynamic alterations

1 reference

https://api.crossref.org/works/10.1038%2FKI.1992.28

7 January 2021

Hypertension in autosomal dominant polycystic kidney disease

1 reference

https://api.crossref.org/works/10.1038%2FKI.1992.28

7 January 2021

The progression of renal disease

1 reference

https://api.crossref.org/works/10.1038%2FKI.1992.28

7 January 2021

Relationships of the renin-angiotensin-aldosterone system and sodium balance to blood pressure regulation in chronic renal failure of polycystic kidney disease

1 reference

https://api.crossref.org/works/10.1038%2FKI.1992.28

7 January 2021

The renin-angiotensin-aldosterone system and autosomal dominant polycystic kidney disease

1 reference

https://api.crossref.org/works/10.1038%2FKI.1992.28

7 January 2021

Renal protective effect of strict blood pressure control with enalapril therapy

1 reference

https://api.crossref.org/works/10.1038%2FKI.1992.28

7 January 2021

A highly polymorphic DNA marker linked to adult polycystic kidney disease on chromosome 16

1 reference

https://api.crossref.org/works/10.1038%2FKI.1992.28

7 January 2021

Pharmacodynamics of converting enzyme inhibition: the cardiovascular, endocrine and autonomic effects of MK421 (enalapril) and MK521

1 reference

https://api.crossref.org/works/10.1038%2FKI.1992.28

7 January 2021

Application of Heyrovsky's inulin method to automatic analysis

1 reference

https://api.crossref.org/works/10.1038%2FKI.1992.28

7 January 2021

Renal extraction of para-aminohippurate and creatinine measured by continuous in vivo sampling of arterial and renal-vein blood

1 reference

https://api.crossref.org/works/10.1038%2FKI.1992.28

7 January 2021

Urinary kallikrein and systemic prostacyclin synthesis during sodium chloride infusion in normal man

1 reference

https://api.crossref.org/works/10.1038%2FKI.1992.28

7 January 2021

Frusemide, ACE inhibition, renal dopamine and prostaglandins: acute interactions in normal man.

1 reference

https://api.crossref.org/works/10.1038%2FKI.1992.28

7 January 2021

Estimating renin participation in hypertension: Superiority of converting enzyme inhibitor over saralasin

1 reference

https://api.crossref.org/works/10.1038%2FKI.1992.28

7 January 2021

Role of the intrarenal renin-angiotensin system in the control of renal function

1 reference

https://api.crossref.org/works/10.1038%2FKI.1992.28

7 January 2021

Cyst formation and growth in autosomal dominant polycystic kidney disease

1 reference

https://api.crossref.org/works/10.1038%2FKI.1992.28

7 January 2021

The anatomy of the renin-secreting cell in adult polycystic kidney disease

1 reference

https://api.crossref.org/works/10.1038%2FKI.1992.28

7 January 2021

Dose-dependent stimulation and inhibition of proximal tubular sodium reabsorption by angiotensin II in the rat kidney

1 reference

https://api.crossref.org/works/10.1038%2FKI.1992.28

7 January 2021

Role of hydrostatic and oncotic pressures in renal sodium reabsorption.

1 reference

https://api.crossref.org/works/10.1038%2FKI.1992.28

7 January 2021

Correction of abnormal renal blood flow response to angiotensin II by converting enzyme inhibition in essential hypertensives

1 reference

https://api.crossref.org/works/10.1038%2FKI.1992.28

7 January 2021

Captopril-induced changes in prostaglandin production: relationship to vascular responses in normal man

1 reference

https://api.crossref.org/works/10.1038%2FKI.1992.28

7 January 2021

Renal vasodilation by converting enzyme inhibition. Role of renal prostaglandins.

1 reference

https://api.crossref.org/works/10.1038%2FKI.1992.28

7 January 2021

A comparison of the effects of prostaglandins E2 and I2 on renal function and renin release in salt-loaded and salt-depleted anaesthetized dogs

1 reference

https://api.crossref.org/works/10.1038%2FKI.1992.28

7 January 2021

Relevance of urinary 6-keto-prostaglandin F1 alpha determination

1 reference

https://api.crossref.org/works/10.1038%2FKI.1992.28

7 January 2021

Vascular sensitivity to prostaglandin I2 and urinary excretion of 6-keto-prostaglandin F1 alpha in conscious dogs

1 reference

https://api.crossref.org/works/10.1038%2FKI.1992.28

7 January 2021

Evidence for an extra-renal origin of urinary prostaglandin E2 in healthy men

1 reference

https://api.crossref.org/works/10.1038%2FKI.1992.28

7 January 2021

Renal hemodynamics and renal kinins after angiotensin-converting enzyme inhibition

1 reference

https://api.crossref.org/works/10.1038%2FKI.1992.28

7 January 2021

The renal kallikrein-kinin system and sodium excretion

1 reference

https://api.crossref.org/works/10.1038%2FKI.1992.28

7 January 2021

Antiadrenergic Antihypertensive Drugs: Their Effect on Renal Function

1 reference

https://api.crossref.org/works/10.1038%2FKI.1992.28

7 January 2021

The effects of selective beta-adrenoceptor antagonists and partial agonist activity on renal function during exercise in normal subjects and those with moderate renal impairment

1 reference

https://api.crossref.org/works/10.1038%2FKI.1992.28

7 January 2021

Therapeutic advantage of converting enzyme inhibitors in arresting progressive renal disease associated with systemic hypertension in the rat

1 reference

https://api.crossref.org/works/10.1038%2FKI.1992.28

7 January 2021

Contrasting renal haemodynamic responses to the angiotensin converting enzyme inhibitor enalapril and the beta-adrenergic antagonist metoprolol in essential hypertension

36

1 reference

5 December 2023

Identifiers

DOI

10.1038/KI.1992.28

1 reference

27 May 2018

Dimensions Publication ID

0 references

1 reference

27 May 2018